Drug intelligence / Profile preview

autologous adipose-derived mesenchymal stem cells (The Foundation for Orthopaedics and Regenerative Medicine)

Development stage
Unknown
Lead developer
The Foundation for Orthopaedics and Regenerative Medicine
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Autologous adipose-derived mesenchymal stem cells (AD-MSCs) is a cell therapy being evaluated by The Foundation for Orthopaedics and Regenerative Medicine for the treatment of cerebral palsy. The treatment involves the extraction of mesenchymal stem cells from the patient's own adipose tissue, which are then expanded in culture and administered via intravenous infusion. These cells are hypothesized to exert therapeutic effects through the secretion of paracrine factors, including neurotrophic and anti-inflammatory cytokines, which may help reduce neuroinflammation and promote the repair or protection of damaged neural tissues in patients with cerebral palsy.

Other names
autologous AD-MSCscultured autologous adult adipose derived mesenchymal stem cells

Beyond the preview

Go deeper on autologous adipose-derived mesenchymal stem cells (The Foundation for Orthopaedics and Regenerative Medicine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous adipose-derived mesenchymal stem cells (The Foundation for Orthopaedics and Regenerative Medicine).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call